forecast
Aging Population Drives Long-Term Pharma R&D Growth
Pharmaceutical R&D spending should grow over the long term because of rising healthcare demand from aging populations, with the WHO projecting the population over 60 to nearly double by 2050, which is a structural tailwind for Agilent.
forecastpending
Speaker
MarcEvidence Quote
“Things like that are just going to drive healthcare spend, in our opinion, in one direction. And that's a tailwind for Agilent.”
Created: 11/12/2026, 11:55:35 AM
Your notes
Loading notes...